DeepSight™ Technology Welcomes Dr. Diku Mandavia, M.D. as New Chief Medical Officer: A Game-Changer in Medical Innovation

SANTA CLARA, Calif., Jan. 14, 2025 /PRNewswire/ — DeepSight Technology, known for its advanced work in medical devices, has appointed Dr. Diku Mandavia as its new Chief Medical Officer. He will lead the medical direction for DeepSight’s innovative ultrasound products like the NeedleVue™ Ultrasound System, OnPoint™ Imaging, and EchoLux™ Ultrasound System.

“We are excited to welcome Dr. Mandavia to DeepSight,” said Nader Sadrzadeh, the Founder and CEO. His deep knowledge in ultrasound and clinical medicine will be vital as we innovate our technology. Dr. Mandavia has successfully brought many medical devices to market and is committed to improving patient care.”

Dr. Mandavia is a board-certified emergency physician with over 20 years of experience. He is well-respected in the field of ultrasound and has been a leader in point-of-care ultrasound technology. Before joining DeepSight, he was the Chief Medical Officer at FujiFilm and Sonosite, where he directed major clinical programs and helped develop new imaging solutions. His expertise in technology and AI will greatly support DeepSight’s mission of improving patient outcomes and clinical processes.

“I’m honored to join DeepSight as CMO,” Dr. Mandavia stated. “I’m impressed by the company’s focus on clinical impact and innovation. I look forward to collaborating with the team to advance technology for healthcare providers and patients worldwide.”

About DeepSight™ Technology

DeepSight Technology is an innovator in medical devices, specializing in advanced ultrasound solutions like the NeedleVue™ Ultrasound system, which enhances needle guidance, and the EchoLux™ Ultrasound System, known for its diagnostic capabilities. Their imaging platforms use cutting-edge analytics and technology to deliver insights that empower medical professionals, striving to revolutionize patient care with precision and accuracy.

SOURCE DeepSight Technology, Inc.